A similar trend was observed in pazopanib-resistant Caki-1 cells but did not reach statistical significance.
← all excerpts
Metabolomics Reveals Tyrosine Kinase Inhibitor Resistance-Associated Metabolic Events in Human Metastatic Renal Cancer Cells.
1
—
—